Clinical Trials Browser

OTHER × Observational × Genitourinary × Clear all

NCT03620786 2026-04-16

HIFU for Focal Ablation of Prostate Tissue: An Observational Study

Prostatic Neoplasms

NCT04286386 2026-04-16

Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam

Active not recruiting

Prostate Adenocarcinoma

NCT05497024 2026-04-16

Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing

Prostatic Neoplasms

NCT07264088 2026-04-16

FOLLOW-UP

Not yet recruiting

100,000 enrolled

Prostatic Neoplasms

NCT07533344 2026-04-16

PSMA-MRI BX

Prostatic Neoplasms

NCT03193970 2026-04-15

Measuring Surgical Recovery After Radical Cystectomy

Urinary Bladder Neoplasms

NCT05424783 2026-04-15

MAGIC

Prostatic Neoplasms

NCT07531329 2026-04-15

DEPICT

Disease, Prostatic Neoplasms

NCT03846128 2026-04-14

BIOSUNTOX

Kidney Neoplasms

NCT07117227 2026-04-14

RCCETT

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07527637 2026-04-14

Risk of Scrotal Hydroceles After Nephrectomy For Kidney Cancer

40,000 enrolled

Testicular Hydrocele, Kidney Neoplasms

NCT07529418 2026-04-14

BALANCE

Not yet recruiting

Prostatic Neoplasms

NCT07529639 2026-04-14

Tumor Budding and T1 Substaging in Urothelial Bladder Cancer

Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Disease Progression

NCT04416646 2026-04-13

ZEBRA

Carcinoma, Renal Cell

NCT05210933 2026-04-13

SMART

Kidney Neoplasms

NCT06060873 2026-04-13

MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial

Testicular Neoplasms

NCT07525349 2026-04-13

Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer

Not yet recruiting

Tertiary Lymphoid Structures, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT02087852 2026-04-09

Kidney Cancer DNA Registry

Kidney Neoplasms

NCT07511517 2026-04-09

BladMetrix

Active not recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Hypersensitivity

NCT05478694 2026-04-08

Outcomes of Focal Ablation for Prostate Cancer

Prostatic Neoplasms

NCT07516886 2026-04-08

PPSARP

Adenocarcinoma, Disease, Prostatic Neoplasms

NCT02400944 2026-04-07

Determinants of Bladder Cancer Recurrence Study (The DETER Study)

Active not recruiting

Urinary Bladder Neoplasms

NCT05334069 2026-04-07

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

BreastDermatologicGastrointestinalGenitourinaryHead & NeckLymphoidMyeloidOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Esophageal Neoplasms, Lung Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06039085 2026-04-07

RARP EI

Prostatic Neoplasms

NCT07514897 2026-04-07

Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring

Urinary Bladder Neoplasms

NCT03841149 2026-04-03

VolUS3D

Carcinoma, Renal Cell, Renal Insufficiency, Chronic

NCT02664883 2026-04-02

Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer

Active not recruiting

Carcinoma, Renal Cell

NCT06532422 2026-04-01

NEPHRAMBU

Kidney Neoplasms

NCT07234656 2026-04-01

PP-RECURK

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04357925 2026-03-31

QoLProstateMQ

Active not recruiting

Prostatic Neoplasms

NCT07503795 2026-03-31

Outcomes of Definitive Radiotherapy for Bladder Cancer

Not yet recruiting

Urinary Bladder Neoplasms

NCT05975775 2026-03-30

LORP

Prostatic Neoplasms

NCT06350734 2026-03-30

Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study

Urinary Bladder Neoplasms

NCT06389097 2026-03-30

(SEEtoTREAT)

Prostatic Neoplasms

NCT06672926 2026-03-30

NEWPROMRI

Prostatic Neoplasms

NCT07478536 2026-03-30

CHAS3

Not yet recruiting

Neoplasms, Prostatic Neoplasms

NCT07494864 2026-03-27

MiLUT

Non-Muscle Invasive Bladder Neoplasms

NCT05931419 2026-03-25

RECOVER

Prostatic Neoplasms

NCT06447064 2026-03-25

(CLOCS-2)

GastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT07481851 2026-03-25

Skin Conductance for Predicting Spinal Anesthesia-Induced Hypotension in Geriatric Urologic Oncology Patients

Hypotension, Urologic Neoplasms

NCT07492927 2026-03-25

Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer

Clinically Significant Prostate Cancer

NCT06762379 2026-03-24

L2-267

Prostatic Neoplasms

NCT07491198 2026-03-24

ONSD-RALP

Pneumoperitoneum, Prostatic Neoplasms

NCT07491406 2026-03-24

PRS-AS

Genetic Risk Score, Prostatic Neoplasms

NCT05096338 2026-03-23

PCT

Active not recruiting

Cardiovascular Diseases, Prostatic Neoplasms, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

NCT07225127 2026-03-23

CISTO2

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06721260 2026-03-20

METRICS

Urinary Bladder Neoplasms, Cachexia

NCT07484971 2026-03-20

CLIQQC

Adenocarcinoma, Disease, Neoplasms, Prostatic Neoplasms

NCT07485257 2026-03-20

MP-PET-MRI

Prostatic Neoplasms

NCT07485881 2026-03-20

18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients

Not yet recruiting

Prostatic Neoplasms